HK Neopharm Limited is one of the most reliable manufacturers and suppliers of afatinib dimaleate in China, featured by quality products and good price. Please rest assured to buy afatinib dimaleate in stock here and get quotation from our factory. Customized orders are welcome.
Afatinib Dimaleate API (CAS 850140-73-7) is a second-generation irreversible targeted anti-tumor API that delivers broad-spectrum ErbB family receptor blockade and acts as key raw material for EGFR-mutant non-small cell lung cancer drugs. This Afatinib Dimaleate Raw Material forms covalent target binding for long-lasting inhibition and full blocking of tumor signaling pathways, with clear clinical targeting for precise therapy of advanced or metastatic NSCLC to support stable disease control.
Technical Specifications
|
Product Name |
Afatinib Dimaleate API |
|
Synonyms |
Afatinib Dimaleate Powder, Afatinib Dimaleate Raw Material |
|
Characteristics |
A white White to light yellow crystalline powder |
|
CAS Number |
850140-73-7 |
|
Assay |
≥99.0% (HPLC, Subject to the COA) |
|
Formula |
C24H25ClFN5O3 |
|
Package |
Technical Package |
|
Storage |
Store at 2-8°C,Protect from light, tightly closed and preserve in a cool, dry place. |
|
Structure |
|
Afatinib Dimaleate API (CAS 850140-73-7) is produced via controlled synthesis and refined quality monitoring per international standards, with consistent purity and excellent batch reproducibility. As a key tyrosine kinase inhibitor raw material, it supports R&D, clinical registration and industrial production. As trusted China Afatinib Dimaleate manufacturers, we ensure stable output.
Product Features
Afatinib Dimaleate API (CAS 850140-73-7) is manufactured with optimized synthesis and full-process quality control to effectively reduce impurities, with its purity and crystal stability meeting pharmaceutical-grade standards to lay a solid foundation for formulation R&D and production.
As an irreversible ErbB family inhibitor API, it features precise target action and sustained inhibitory effects, efficiently blocking tumor cell signal transduction and providing distinct advantages in targeted anti-tumor drug development.
Our Afatinib Dimaleate Powder shows excellent batch consistency and stable physicochemical properties compatible with various formulation processes, covering demands from preclinical research, clinical trials to commercial production and supporting large-scale supply.
Produced in accordance with international pharmacopoeia and drug registration standards, it meets high industry benchmarks with outstanding safety and reliability, supporting the R&D and registration of targeted anti-tumor medicines. We also provide Customized Afatinib Dimaleate to meet specific project requirements.
Full-Cycle Quality Control & Consistent Quality
Afatinib Dimaleate API (CAS 850140-73-7) applies a full-cycle quality management system covering raw material selection, process optimization and finished product testing, with strict compliance to pharmacopoeial and internal standards ensuring all key indicators are qualified from the source.
Supported by refined quality monitoring technologies, it enables dynamic control of purity, related substances, moisture and crystal form, with standardized HPLC testing and real-time data tracking maintaining stable quality for every batch.
We focus on long-term quality stability by continuously improving production and storage conditions and conducting regular quality reviews. Process and system upgrades ensure consistent batch performance and lasting reliability for downstream formulation R&D and production. Afatinib Dimaleate in stock supports fast order response.
Application Scenarios
Afatinib Dimaleate API (CAS 850140-73-7) is a core raw material for targeted anti-tumor therapy. With reliable quality and clear pharmacological mechanism, it is widely applied in innovative drug R&D, clinical trials and industrial production, strongly supporting the development of clinical targeted medicines.
It is mainly used in NSCLC targeted drug R&D as core raw material for formulation design and process validation, meeting strict preclinical requirements for purity, stability and safety. It is suitable for anti-tumor clinical trial stage with quality fully complying with global registration regulations, supporting large-scale preparation of clinical materials with uniform and consistent batch quality.
It can be used in industrial mass production of approved marketed formulations, meeting continuous commercial supply needs and helping downstream manufacturers achieve standardized production. As professional China Afatinib Dimaleate suppliers, we deliver stable and consistent capacity.
It also supports innovative research by institutions and pharmaceutical companies for novel targeted combination therapies, expanding precision oncology options and improving clinical drug accessibility.
Packaging and Transportation
The packaging and transportation system for Afatinib Dimaleate API (CAS 850140-73-7) strictly follows pharmaceutical API regulations. Combined with storage properties and logistics safety, standardized sealed packaging ensures product stability during circulation and reliable support for downstream applications.
The product is packed in food-grade HDPE drums with moisture-proof and oxygen-barrier liners. The double-sealed structure effectively isolates moisture and impurities, with sizes suitable for industrial transport and clear labeling for easy identification and management.
Transportation is conducted via cold chain at 2–8°C with temperature and light control. Professional shockproof packaging avoids physical damage and maintains stable physicochemical properties during long-distance delivery.
A complete traceability system covers warehousing, shipment and delivery with detailed logistics records. Dedicated staff monitor transport status and respond promptly to abnormalities, ensuring safe and on-time delivery. Afatinib Dimaleate made in China is well recognized by global partners.
Our Advantages
Afatinib Dimaleate API is produced through self-optimized synthesis to achieve high purity and low impurities, with key quality indicators exceeding pharmacopoeial standards and strengthening quality support for downstream formulation R&D and production.
A closed-loop full-process quality control system is implemented from raw material traceability to finished product release, ensuring excellent batch consistency and meeting full-cycle supply demands from clinical research to commercial production.
We possess mature large-scale production capacity and complete logistics systems, supporting flexible order volumes and ensuring on-time, high-quality delivery with reliable supply chain support. Clients are welcome to buy Afatinib Dimaleate under flexible terms.
Production complies with ICH, USP and global regulatory requirements. Complete registration dossiers are available to support efficient drug R&D and registration progress.
A professional technical team provides customized process optimization and quality research support, responding quickly to customer needs and offering full technical assistance for partner drug development projects.
FAQ
The company operates per pharmaceutical manufacturing regulations, focusing on product compliance and clinical safety, and develops Afatinib Dimaleate API (CAS 850140-73-7). From technical breakthroughs to large-scale supply, it supports targeted lung cancer drug R&D. We cooperate deeply with global clients to empower pharmaceutical innovation and build a win-win industrial ecosystem.
Hot Tags: afatinib dimaleate, China afatinib dimaleate manufacturers, suppliers, factory
